The chimeric toxin was injected into the tumors on eight occasions, which reduced the tumor volume by 67% compared to control animals [i.e., tumor-bearing mice treated with phosphate-buffered saline (PBS)], suggesting the therapeutic potential of the PD1-DT chimeric toxin for eradicating solid tumors (65). The gene discussed is PDCD1; the disease is neoplasm.